May 11, 2018 / 12:35 PM / 3 months ago

BRIEF-Eyegate Pharmaceuticals Posts Q1 Revenue Of $1.096 Million

May 11 (Reuters) - EyeGate Pharmaceuticals Inc:

* EYEGATE PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

* Q1 REVENUE $1.096 MILLION VERSUS $185,000

* NET LOSS IN Q1 OF 2018 WAS $2.38 MILLION, COMPARED WITH $2.92 MILLION IN Q1 OF 2017 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below